IsoTherapeutics Group, LLC
Partners in radiopharmaceutical R&D and manufacturing needs
IsoTherapeutics Group, LLC is an early-stage radiopharmaceutical R&D and cGMP Manufacturing company that has earned a solid reputation with its customers and collaborators in radiochemistry, radiolabeling, preclinical studies, and process & product development. IsoTherapeutics has capabilities to help customers with radiopharmaceutical manufacturing for clinical trials. This helps ensure seamless development from research to manufacturing. IsoTherapeutics has a robust quality system to help customers meet regulatory requirements.
IsoTherapeutics has a dedicated small animal facility for in vivo GLP studies.
IsoTherapeutics performs fee-for-service R&D, meeting agreed upon deliverables. We are flexible and open to a variety of business models for a win-win outcome.
IsoTherapeutics is also developing its own therapeutic radiopharmaceutical technologies. CycloSam® technology, developed for treatment of pediatric osteosarcoma, metastatic bone cancer and bone marrow ablation, was recently out-licensed to QSAM Biosciences. BetaBrach™ has been developed for targeted treatment of bone metastases and solid inoperable tumors, and is available for licensing.
Please visit us at www.isotherapeutics.com. Feel free to contact us to discuss your project.
Brands: IsoTherapeutics Group®, LLC
CycloSam®
BetaBrach™